Out of the 116 patients in the sample, there was a predominance of female subjects n=72, 62.1%, of which 40 68.9% were in the placebo group and 32 55.2% in the experimental group p=0.180.
De los 116 pacientes que compusieron la muestra hubo una predominancia del sexo femenino n=72; 62,1%, de los cuales 40 68,9% pertenecían al grupo placebo y 32 55,2% al grupo experimental p=0,180.
Dos 116 pacientes que compuseram a amostra, houve predominância do sexo feminino n=72; 62,1%, 40 68,9% pertenciam ao grupo placebo e 32 55,2% ao grupo experimental p=0,180.